Simulect

Medicinal product

(Invented) name

Simulect

Active substance (s)

Baziliksimabas

Strength

20 mg

Pharmaceutical form

milteliai injekciniam ar infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AC02, Basiliximab

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

1998-10-09

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for solution for injection or infusion	1 vnt.
Baziliksimabas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111793	97908	1097908	flakonas	N1		Receptinis	EU/1/98/084/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
1998-10-09	Registruotas